Edgewell (EPC) Q3 2026 Earnings Call Transcript

Edgewell (EPC) reported Q3 FY2026 net sales of $570.1 million, up 1.7% reported and 1.1% organic, with North America organic growth of 3.0% and international down 1.4% due to Middle East and supply disruptions. Adjusted EPS was $0.72. Full-year guidance: organic net sales flat to 0.5%, adjusted EPS $1.80-$2.00, EBITDA $250-$260 million.

Original reporting
Published Aug 16, 2026, 5:04 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 16, 2026, 1:46 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Edgewell (EPC) Q3 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$EPCNeutralMed
01

Why it matters

The most tradable elements are the updated full-year guidance ranges (organic sales flat to +0.5%, adjusted EPS $1.80-$2.00, adjusted EBITDA $250M-$260M, adjusted FCF $80M-$110M) and the quantified margin and cost headwinds (gross margin down 30 bps, 160 bps inflation and tariffs headwind).

02

Market read

Traders can use the narrowed guidance and quantified headwinds to reassess near-term earnings power, margin trajectory, and execution risk from manufacturing network transition.

03

What to watch

Adjusted EBITDA declined year over year despite productivity savings, suggesting that higher brand investment and incentives are not yet translating into operating leverage; investors may underweight the sustainability of the 44.5% gross margin level.

Relevance 8/10Novelty 8/10Timing: ahead of the Aug. 5 earnings-call market reaction and positioning for FY guidance

Background

Edgewell’s Q3 FY2026 call centers on a shift back to organic net sales growth in North America, post Feminine Care divestiture, while consolidating Wet Shave manufacturing and navigating tariffs, inflation, and Middle East-related supply disruption.

Company-level read

Ticker impact

$EPCNeutralMedium confidence
Context

Edgewell reported Q3 FY2026 net sales of $570.1M and guided FY adjusted EPS to $1.80-$2.00, narrowing ranges amid margin and tariff headwinds.

Expected impact

Near-term trading likely hinges on whether investors view the narrowed FY ranges and organic growth inflection as offsetting the 44.5% gross margin decline and international disruption.

Evidence & confidence

The article provides concrete Q3 results and updated full-year guidance (sales, EPS, EBITDA, FCF) plus quantified headwinds (160 bps inflation and tariffs, 30 bps gross margin decline) and a specific operational catalyst (Wet Shave manufacturing consolidation).

Market effects

Personal care and branded consumer staples investors may reprice peers’ expectations for organic growth durability versus promotional/mix-driven margin pressure.

International organic sales weakness is explicitly tied to Middle East conflict and temporary European and Latin America supply disruptions, which can influence regional risk premia for similar supply-chain-exposed brands.

Tariff and inflation headwinds quantified (160 bps) may reinforce broader cost-pressure assumptions for consumer packaged goods supply chains.

Counterpoint

The organic growth inflection may be partly temporary, with international weakness tied to transitory supply disruptions and Wet Shave consolidation creating ongoing execution risk.

Key entities

  • Edgewell Personal Care Company

    Reported Q3 FY2026 results and provided full-year guidance, including organic sales growth inflection and Wet Shave manufacturing consolidation impacts.

  • Rod Little

    CEO who highlighted Wet Shave manufacturing consolidation as the largest operational initiative since 2015 and discussed brand momentum (Cremo, Hawaiian Tropic).

  • Francesca Weissman

    CFO who attributed international organic sales decline to Middle East conflict and transitory supply chain impacts, and discussed inflation and input cost pressures.

Related articles

$EPCMed

Edgewell Reports 3% Q4 Sales Growth and Adjusted EPS of $0.78

Edgewell reported Q4 2026 net sales of $484.1M, up 3.0%, and adjusted EPS of $0.78. Full-year sales rose 1.8% to $1.997B, with adjusted EPS at $1.93. The company forecasted fiscal 2027 adjusted EPS of $1.85 to $2.15. Growth was driven by North America and International markets, with notable gains in Grooming and Sun and Skin Care segments.

$EPCMed

Edgewell Personal Care beats Q4 estimates on revenue growth

Edgewell Personal Care (EPC) reported Q4 adjusted EPS of $0.78, beating estimates by $0.01, with revenue of $484.1M, up 3.0% YoY. Organic sales grew 3.1%, driven by Wet Shave and Sun & Skin Care segments. Adjusted gross margin expanded 510 bps to 45.7%. For fiscal 2027, EPC guided adjusted EPS to $1.85-$2.15 and organic net sales growth of 1.0%-3.0%.

$EPCMed

Edgewell Personal Care Announces Fourth Quarter and Fiscal 2026 Results

EDGEWELL PERSONAL CARE Co (EPC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Edgewell Personal Care Company 6 Research Drive Shelton, Conn 06484 FOR IMMEDIATE RELEASE Company Contact Chris Gough Vice President, Investor Relations 203-944-5706 Chris.Gough@Edgewell.com Edgewell Personal Care Announces Fourth Quarter and Fiscal 2026 Results Four

$EPCHighAI 8/10

Edgewell Personal Care Announces Fourth Quarter and Fiscal 2026 Results

Edgewell Personal Care (EPC) reported Q4 2026 net sales of $484.1M, up 3.0%, and full-year sales of $1.996B, up 1.8%. GAAP EPS was $0.23 for Q4 and $(0.05) for the year, while adjusted EPS was $0.78 and $1.93, respectively. The company expects fiscal 2027 growth in organic sales, adjusted EBITDA, and adjusted EPS. EPC ended Q4 with $375.6M in cash and declared a $0.15 dividend.

$EPCMed

Edgewell’s (EPC) Margins Slip Even As North America Rebounds

Edgewell Personal Care (EPC) reported Q3 2026 results with net sales up 1.7% to $570.1M, driven by North America's 3.0% organic growth. However, operating income fell 44% due to margin declines and higher costs. Adjusted EPS held at $0.72, matching prior year. CEO Rod Little called it an 'important step forward.'